Searchable abstracts of presentations at key conferences in endocrinology

ea0029p914 | Female Reproduction | ICEECE2012

Subcutaneous adipose tissue in women with polycystic ovary syndrome

Aydogdu A. , Tasci I. , Kucukerdonmez O. , Tapan S. , Aydogdu S. , Uckaya G. , Meric C. , Basaran Y. , Sonmez A. , Haymana C. , Baskoy K. , Taslipinar A. , Azal O.

The present study was performed to search whether SCAT increase in women with PCOS. Fifty-two women with PCOS patients and 53 matched healthy controls were participated in the study. Caliper device was used to measure skinfold thickness (SFT). Body fat distributions were determined by bioelectrical impedance analysis. SFT in all defined areas, total body and trunk fat free mass (FFM), and HOMA score were higher in women with PCOS, while adiponectin was significantly lower. SFT...

ea0029p963 | Female Reproduction | ICEECE2012

Epicardial adipose tissue thickness in patients with polycystic ovary syndrome

Aydogdu A. , Uckaya G. , Tasci I. , Baysan O. , Tapan S. , Bugan B. , Serdar M. , Aydogdu S. , Akbulut H. , Aydogan U. , Sonmez A. , Azal O.

EAT has been linked to the presence and severity of cardiovascular disease. EAT has been linked to the presence and severity of cardiovascular disease. We searched if the patients with PCOS have increased EATT, or not.Total of 41 subjects with PCOS and 46 age and body mass index (BMI) matched healthy controls were enrolled. EAT was measured by echocardiography.EATT and HOMA-IR score were significantly higher (P=0.0001 for bo...

ea0029p964 | Female Reproduction | ICEECE2012

High plasma level of long pentraxin 3 is associated with insulin resistance in women with polycystic ovary syndrome

Aydogdu A. , Tasci I. , Tapan S. , Basaran Y. , Aydogan U. , Meric C. , Sonmez A. , Aydogdu S. , Akbulut H. , Taslipinar A. , Haymana C. , Uckaya G. , Azal O.

PCOS is characterized by insulin resistance. Inflammation has been anticipated to play role in the pathogenesis of both insulin resistance and atherosclerosis. Pentraxin 3 (PTX3) is an inflammatory mediator synthesized in a variety of cells and tissues. In the present study, serum PTX3 level and its relationship with insulin resistance were investigated in patients with PCOS. In total, 40 patients with PCOS and 40 age and body mass index (BMI) matched healthy controls were enr...

ea0032p234 | Clinical case reports – Pituitary/Adrenal | ECE2013

Combined choroidal neovascularization and hypopituitarism in a patient with homozygous mutation in methylenetetrahydrofolate reductase gene

Aydogdu Aydogan , Haymana Cem , Baskoy Kamil , Durukan Ali Hakan , Ozgur Gokhan , Azal Omer

Introduction: Hypopituitarism is defined as either partial or complete deficiency of anterior or posterior pituitary hormone secretion or both. Hypopituitarism itself may increase the risk of thromboembolism/hypercoagulopathy, and underlying mechanisms of hemostatic dysfunctions in hypopituitarism are mostly unknown. Reduced enzymatic activity due to methylenetetrahydrofolate reductase (MTHFR) gene mutations are associated with hyperhomocysteinemia and have been linked to both...

ea0022p148 | Cardiovascular endocrinology and lipid metabolism | ECE2010

Searching for the metabolic syndrome criteria in young adults with hypogonadism

Sonmez Alper , Haymana Cem , Bolu Erol , Tapan Serkan , Barcin Cem , Aydogdu Aydogan , Taslipinar Abdullah , Kutlu Mustafa

Introduction: The evidence shows that the prevalence of metabolic syndrome is increased in patients with hypogonadism. However, much of the data regarding this association comes from the elderly patients with obesity, hypertension or type 2 diabetes. The total testosterone levels alter physiologically in these conditions and thus can falsify the association. We aimed to investigate the prevalence of the metabolic syndrome in young adults with hypogonadism who do not have any c...

ea0022p162 | Cardiovascular endocrinology and lipid metabolism | ECE2010

The effect of testesterone replacement therapy on HDL subfraction levels in hypogonadotropic hypogonadism

Taslipinar Abdullah , Sonmez Y Alper , Bolu Erol , Tapan Serkan , Uckaya Gokhan , Aydogdu Aydogan , Kutlu Mustafa

The high-density lipoprotein (HDL) levels are decreased in paitents with hypogonadotropic hypogonadism (HH). Although testosteron regulates lipoprotein metabolism, the effect of testosterone replacement therapy on HDL metabolism is not clearly shown in HH. The aim of this study is to determine the effects of testesterone replacement on HDL subfractions in young patients with HH. Forty-three cases with HH (mean age 21±2.45 years) were enrolled. Fifty-one healthy volunteer ...

ea0022p320 | Diabetes | ECE2010

Calcaneal spur incidence is increased in patients with type 2 diabetes mellitus

Aydogdu Aydogan , Akbulut Halil , Uckaya Gokhan , Taslipinar Abdullah , Sonmez Y Alper , Aydogan Umit , Kutlu Mustafa

Obesity is a risk factor for calcaneal spur (CS) formation which is supposed to originate from chronic plantar fasciitis. But histological findings support the thesis that ‘plantar fasciitis’ is a degenerative fasciosis without inflammation. Diabetes mellitus may contribute to the risk of CS by decreased ability of tissue repair and increased reactive ossification. Thus, we aimed to determine CS incidence in asymptomatic obese subjects with and without type 2 diabete...

ea0041ep542 | Diabetes therapy | ECE2016

Add on exenatide treatment in obese type 2 diabetic patients under intensive insulin regiments

Sonmez Alper , Dinc Mustafa , Taslipinar Abdullah , Aydogdu Aydogan , Meric Coskun , Basaran Yalcin , Haymana Cem , Demir Orhan , Azal Omer

Introduction: Intensive insulin treatment in obese patients with type 2 diabetes (T2DM) is often difficult. Insulin dosages are much higher, which further increase weight gain and the risk of hypoglycemia. Glucagon like peptide 1 receptor agonists (GLP-1RAs) are the promising treatment modalities causing weight loss and reducing the risk of hypoglycemia. There is no published data about the effect of adding on GLP1RAs to obese T2DM patients with un-controlled glucose levels un...

ea0035p136 | Calcium and Vitamin D metabolism | ECE2014

Functional parathyroid cyst: a rare cause of hypercalcemia

Sacikara Muhammed , Dellal Fatma Dilek , Aydin Cevdet , Cetin Huseyin , Aydogdu Koray , Agackiran Yetkin , Ersoy Reyhan , Cakir Bekir

Primary hyperparathyroidism (PHPT) is usually caused by single adenoma. Functional parathyroid cysts are a rare cause of PHPT. Parathyroid cysts can be subdivided into nonfunctional, without biochemical derangement, or functional, with elevated serum calcium accompanying clinical evidence of hyperparathyroidism. Parathyroid cysts are found in the neck and anterior mediastinum. Functional parathyroid cysts are not only secretary but larger cysts can lead to compression symptoms...

ea0029p1047 | Male Reproduction | ICEECE2012

Visceral adiposity index and the effect of testosterone treatment in young men with congenital hypogonadotropic hypogonadism

Haymana C. , Sonmez A. , Aydogdu A. , Taslipinar A. , Meric C. , Basaran Y. , Baskoy K. , Tapan S. , Uckaya G. , Bolu E. , Azal O.

Introduction: Visceral adipose tissue (VAT) is closely related to metabolic derangement, such as dyslipidemia insulin resistance and type 2 diabetes. Also, there is an increase in deposition of visceral adipose tissue in hypogonadal subjects. The visceral adiposity index (VAI) is a sex-specific mathematical index, based on waist circumference (WC), body mass index (BMI), triglycerides (TG) and HDL cholesterol (HDL) levels, indirectly expressing visceral adipose function. We in...